Welcome to BioSeeker Group!

HCV R&D and Business Development Database

Additional Information

Published Date Jun 22, 2004
Format CD-ROM
Publisher BioSeeker Group

Availability: In stock

$1,950.00

Quick Overview

This CD-ROM product is one of the most comprehensive and up to date information sources on chronic hepatitis C virus R&D and business development.

Request Sample Pages or Access via 1stOncology™

  • You can request Free Sample Pages to HCV R&D and Business Development Database.

    To find out more about HCV R&D and Business Development Database, please read the product description below.
    We also are happy to email you out free sample pages which contain screen shots and more information on the methodology behind the product.

    Did you know that HCV R&D and Business Development Database is part of the 1stOncology™ platform and can be accessed at no extra cost?

    1stOncology™ allows you to always stay on top of what is really going on in the world of cancer drug development and have an edge when it comes to Search & Evaluation, Indication Selection & Expansion, Target Scouting, First-in-Class analysis and much, much more.


    Or

Executive Summary

This unique CD-ROM database product is one of the most comprehensive and up to date information sources on chronic hepatitis C virus R&D and business development. The database contains extensive corporate, R&D, and business collaboration information. The company profile database covers over 150 companies from 18 different countries. The R&D database covers over 160 pipeline drugs from early stage as target validation to late stage as phase III. All projects have as far as possible been assigned with specified targets, such as IMPDH, RdRp, P7 etc, and mechanism, such as anti-fibrotic, antisense, immune modulator etc. In the collaboration database more than 80 unique business collaborations have been described. Read more about general and specifics about each database below.

Contents

  • R&D activities
  • Business interaction
  • News
  • Company profiles

The R&D information is structured into 11 searchable segments

  • Investigator
  • Drug name
  • Combinatory drugs
  • Developmental stage
  • Indication
  • Sub-indication
  • Therapy given
  • Drug Effects
  • Mechanisms/Targets
  • General comments
  • Source of data

The business interaction information includes

  • Collaborators
  • Type of collaboration
  • Date
  • Description
  • Terms

Company profile includes

  • Company
  • Contact details (address, phone, fax, email, url)
  • Short company description

CD Features

- All data are compiled into a searchable database, search functions include:

  • Free text search in all data
  • Specific search for all ; R&D, Business Interaction type, location, profile etc.

- Review companies, drug pipelines, business interactions, and breaking news through any of its sub categories, i.e. by country, developmental stage, target, type of business interaction etc.

- Through direct link to company web page from inside the application you can make further investigation to any company of interest.

- Send emails directly from the CD.

System Requirements

  • AMD-Athlon/Pentium II PC
  • Windows 98/NT4/2000/ME/XP
  • 8x-speed CD Rom drive
  • SVGA 16 bit display. (32 bit recommended)
  • 32 MB of available RAM (128 MB recommended)
  • Internet access (to test web-enabled presentations)

Request Sample Pages or Access via 1stOncology™

  • You can request Free Sample Pages to HCV R&D and Business Development Database.
    To find out more about HCV R&D and Business Development Database, please read the product description below.
    We also are happy to email you out free sample pages which contain screen shots and more information on the methodology behind the product.

    Did you know that HCV R&D and Business Development Database is part of the 1stOncology™ platform and can be accessed at no extra cost?

    1stOncology™ allows you to always stay on top of what is really going on in the world of cancer drug development and have an edge when it comes to Search & Evaluation, Indication Selection & Expansion, Target Scouting, First-in-Class analysis and much, much more.


    Or

Other selected research from the 'Business Development' category:


Near Term Industry Analysis of US Therapeutic Discovery Programs: A Foretaste on What We can Expect from the US Life Science Industry in the Future
BioSeeker has created this analysis based on more than 2,800 companies and 4,500 projects covering 57 life science categories. Use this analysis to: Find technologies , drugs and devices of value to your company; Benchmark against competitors; Find trends in the current market place; Identify key personnel in companies and much more. Learn More


HCV R&D and Business Development Database
This CD-ROM product is one of the most comprehensive and up to date information sources on chronic hepatitis C virus R&D and business development. Learn More

Other selected research from the 'R&D' category:


Bladder Cancer Drug Pathway Analyzer
There are today at least 141 targeted molecular therapies known to affect more than 219 specific intracellular signaling pathways for the treatment of bladder cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 133 drug targets that are included in this drug-pathway analyzing tool. No less than 123 of these have been recorded with mutations and 30 drug targets have mutations which have been causally implicated in cancer. Learn More


Competitive Outlook on HCV: What to Know and Expect in R&D and Business Development
A fresh look on both the current world status of R&D and business development in HCV. Our research and analysis is built on more than 150 companies from over 18 different countries and include more than 160 pipline drugs in development for HCV. Learn More

Other selected research from the 'Infectious diseases' category:


HCV R&D and Business Development Database
This CD-ROM product is one of the most comprehensive and up to date information sources on chronic hepatitis C virus R&D and business development. Learn More


Market Development in Anti-virals:What is Next?
This analysis deals with 26 of the most promising pharmaceutical companies with anti-viral drugs on the market. Indication by indication is measured by number of current therapies, present sales and sales development. Learn More